Healthcare AI

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Integer massa nulla, tincidunt id magna et, rutrum congue mauris. Nullam a commodo libero, ac pellentesque sapien. Fusce rhoncus urna non risus convallis, et efficitur lorem bibendum. Nulla sed libero posuere, dictum nunc vel, lacinia sem. Donec non mollis massa. Integer ornare sit amet nulla ac consequat. Nullam ut mi sed erat dictum semper sit amet iaculis mi.

Integer magna tortor, ullamcorper at ligula in, ultrices vestibulum sapien. Ut fringilla arcu eu velit blandit vestibulum. Mauris eget magna et purus euismod facilisis. Proin nisi mi, luctus ut pulvinar non, cursus eget sapien. Quisque faucibus vel mi nec tempus. Orci varius natoque penatibus et magnis dis parturient montes, nascetur ridiculus mus. Donec vel arcu nec mi scelerisque sodales suscipit in metus. In hac habitasse platea dictumst. Ut eget consectetur nisl. Vestibulum ornare bibendum justo vitae feugiat. Nam mattis lorem et aliquam lobortis. Suspendisse a est semper, tempor sapien ac, rutrum massa. Ut vitae libero et sem cursus rutrum. Vestibulum id nibh tempor, suscipit felis ut, egestas ligula. Phasellus placerat efficitur sem.

In non massa nec ipsum scelerisque viverra vel ac nisl. Nulla congue mauris id massa aliquam, a fringilla turpis elementum. Pellentesque erat justo, faucibus pulvinar tellus sed, volutpat interdum justo. Mauris cursus, ante in egestas mollis, diam leo varius libero, eu euismod mauris libero euismod lacus. Pellentesque maximus ultricies mauris quis posuere. Etiam leo mauris, feugiat vitae lorem id, placerat rutrum nulla. Integer ullamcorper porttitor augue at ultrices. Praesent efficitur ligula at placerat sodales.

Latest news

Imperial Consultants contribute to novel pain drug success

Imperial Consultants contribute to novel pain drug success

Australian pharmaceutical company, Spinifex Pharmaceuticals (“Spinifex”) has recently presented the clinical development of their lead product at the 14th World Congress of Pain®, highlighting the success of consultancy through Imperial Consultants. read more

Prof David Nethercot appointed as assessor to assist Grenfell Tower Inquiry Chairman

Prof David Nethercot appointed as assessor to assist Grenfell Tower Inquiry Chairman

David Nethercot, Emeritus Professor of Civil Engineering, has been appointed by the Chairman of the Grenfell Tower Inquiry to assist him in considering technical issues relating to the design and construction of the building and its refurbishment. read more

Imperial’s experts to help clean-tech startups

Imperial’s experts to help clean-tech startups

Mayor of London Sadiq Khan announced the launch of Better Futures - an incubator focused on clean-tech startups to be led by Sustainable Bridges and delivered by the GLA, Imperial College London, Imperial Consultants and OPDC (Old Oak and Park Royal Development Corporation). read more

Related case studies

Hepatitis C genotype and drug resistance testing

Hepatitis C genotype and drug resistance testing

Genotype and resistance testing for new direct-acting antiviral (DAA) drugs designed to treat Hepatitis C virus (HCV). read more

Design advice on eco-ventilation system for homes

Design advice on eco-ventilation system for homes

Our consultants shared their expertise in sustainable energy system design to help Clean Tech start up ‘Ventive Ltd’ to move into new markets with their PVHR (passive ventilation with heat recovery) system. read more

Neuropathic pain drug development

Neuropathic pain drug development

Our consultants shared their expertise in neuropathic pain area treatments to support Spinifex’s drug discovery and development programs. read more